Cartia XT Diltiazem Hydrochloride Capsules Recalled for Incorrect Expiration Date
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg due to an incorrect expiration date printed on the label. The affected lot was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II labeling error involving incorrect expiration date information. The source text does not report any hospitalizations, illnesses, or injuries, and this is a labeling/documentation issue rather than a manufacturing defect, making it a moderate-severity precautionary recall.
Plain-English summary
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, 90-capsule bottles, due to an incorrect expiration date on the product label. The affected lot is Lot # 100023805, labeled with an expiration date of 05/2023.
The recalled product was distributed nationwide in the United States. A total of 32,316 bottles are affected by this recall.
Patients currently taking this medication from the affected lot should contact their healthcare provider or pharmacist for guidance. Consumers should not use the affected product and should return it to the pharmacy where it was dispensed or contact the manufacturer for instructions on how to proceed.
The recalled product
- Product
- CARTIA (DILTIAZEM HYDROCHLORIDE)
- Brand
- CARTIA
- Manufacturer
- Teva Pharmaceuticals USA
- Hazard
- mis-labeling
- expiration-date-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 100023805
- Exp. Date 05/2023
UPCs (4)
- 0362037598906
- 0362037599903
- 0362037597909
- 0362037600906
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27